Back
Neurocrine Biosciences Stock Price Chart
Sponsored
NBIX
Sponsored
This DeFi Coin Could 10x Soon... I Advise You Get In Now!
Discover this DeFi diamond before the next surge
Buy
53
NBIX
Neurocrine Biosciences
Last Price:
140.77
Seasonality Move:
8.72%
7 Day Trial
ALL ACCESS PASS
$
7
Election Shock on August 19th?
Click here now to see the evidence I've gathered.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBIX is experiencing slight buying pressure.
Neurocrine Biosciences Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 139.09 | Buy |
20-day SMA: | 136.82 | Buy |
50-day SMA: | 137.3 | Buy |
200-day SMA: | 122.48 | Buy |
8-day EMA: | 139.15 | Buy |
20-day EMA: | 137.89 | Buy |
50-day EMA: | 136.76 | Buy |
200-day EMA: | 125.3 | Buy |
Neurocrine Biosciences Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.79 | Buy |
Relative Strength Index (14 RSI): | 55.92 | Buy |
Chaikin Money Flow: | 71950 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (134.13 - 140.23) | Buy |
Bollinger Bands (100): | (129.26 - 140.84) | Buy |
Neurocrine Biosciences Technical Analysis
Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Neurocrine Biosciences Stock
Is Neurocrine Biosciences Stock a Buy?
- Neurocrine Biosciences share price is 140.71 while NBIX 8-day simple moving average is 139.09, which is a Buy signal.
- The stock price of NBIX is 140.71 while Neurocrine Biosciences 20-day SMA is 136.82, which makes it a Buy.
- Neurocrine Biosciences 50-day simple moving average is 137.30 while NBIX share price is 140.71, making it a Buy technically.
- NBIX stock price is 140.71 and Neurocrine Biosciences 200-day simple moving average is 122.48, creating a Buy signal.
NBIX Technical Analysis vs Fundamental Analysis
Buy
53
Neurocrine Biosciences (NBIX)
is a Buy
Is Neurocrine Biosciences a Buy or a Sell?
-
Neurocrine Biosciences stock is rated a Buy
The current Neurocrine Biosciences [NBIX] share price is $140.71. The Score for NBIX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
Neurocrine Biosciences Stock Info
Market Cap:
14.16B
Price in USD:
140.71
Share Volume:
615.05K
Neurocrine Biosciences 52-Week Range
52-Week High:
148.37
52-Week Low:
89.04
Buy
53
Neurocrine Biosciences (NBIX)
is a Buy
Neurocrine Biosciences Share Price Forecast
-
What is the Neurocrine Biosciences stock price today?
The Neurocrine Biosciences stock price is 140.71 USD today. -
Will NBIX stock go up or go down?
Neurocrine Biosciences> share price is forecast to RISE/FALL based on technical indicators -
Is Neurocrine Biosciences overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Neurocrine Biosciences is not overvalued.
Is Neurocrine Biosciences Stock a Buy?
- Neurocrine Biosciences share price is 140.71 while NBIX 8-day exponential moving average is 139.15, which is a Buy signal.
- The stock price of NBIX is 140.71 while Neurocrine Biosciences 20-day EMA is 137.89, which makes it a Buy.
- Neurocrine Biosciences 50-day exponential moving average is 136.76 while NBIX share price is 140.71, making it a Buy technically.
- NBIX stock price is 140.71 and Neurocrine Biosciences 200-day simple moving average is 125.30, creating a Buy signal.
Fundamental Analysis of Neurocrine Biosciences
Is Neurocrine Biosciences a good investment?
- Analysts estimate an earnings increase this quarter of $0.32 per share, an increase next quarter of $0.03 per share, an increase this year of $1.78 per share, and an increase next year of $1.54 per share.
Technical Analysis of Neurocrine Biosciences
Should I short Neurocrine Biosciences stock?
- NBIX Moving Average Covergence Divergence (MACD) indicator is 0.79, suggesting Neurocrine Biosciences is a Buy
- Neurocrine Biosciences Relative Strength Index (RSI) is 55.92, which suggest Neurocrine Biosciences is overbought
- The Bollinger Bands (25) for Neurocrine Biosciences is (134.13 - 140.23), which suggest Neurocrine Biosciences is a Buy
- The Bollinger Bands (100) for Neurocrine Biosciences is (129.26 - 140.84), which suggest Neurocrine Biosciences is a Buy
* Neurocrine Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.